Search Results - "Faridi, Kamil"

CORDIOPREV and the traditional Mediterranean diet by Faridi, Kamil F.

Get full text

Medicare Coverage and Out-of-Pocket Costs of Quadruple Drug Therapy for Heart Failure by Faridi, Kamil F, Dayoub, Elias J, Ross, Joseph S, Dhruva, Sanket S, Ahmad, Tariq, Desai, Nihar R

“…Beta-blockers, angiotensin receptor-neprilysin inhibitor (ARNI), mineralocorticoid receptor antagonists, and sodium-glucose cotransporter-2 inhibitors…”
Get full text

Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy: Payer Approvals and Rejections, and Patient Characteristics for Successful Prescribing by Hess, Gregory P, Natarajan, Pradeep, Faridi, Kamil F, Fievitz, Anna, Valsdottir, Linda, Yeh, Robert W

“…BACKGROUND:Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) are a novel class of medications for patients with familial hypercholesterolemia…”
Get full text

Severe aortic stenosis detection by deep learning applied to echocardiography by Holste, Gregory, Oikonomou, Evangelos K, Mortazavi, Bobak J, Coppi, Andreas, Faridi, Kamil F, Miller, Edward J, Forrest, John K, McNamara, Robert L, Ohno-Machado, Lucila, Yuan, Neal, Gupta, Aakriti, Ouyang, David, Krumholz, Harlan M, Wang, Zhangyang, Khera, Rohan

“…Abstract Background and Aims Early diagnosis of aortic stenosis (AS) is critical to prevent morbidity and mortality but requires skilled examination with…”
Get full text

Putting saturated fat in context—replacement and total intake matter by Faridi, Kamil F, Kris-Etherton, Penny M, Aspry, Karen E

Get full text

Medication Adherence and Cardiovascular Outcomes by Faridi, Kamil F., MD

“…The differences in characteristics between adherent and less adherent groups further emphasize the need to better incorporate these types of socioeconomic…”
Get full text

Rethinking Our Roots: The Ground-Up Approach to Heart Health & Planetary Sustainability by Saad, Ali, Brandt, Eric J., Faridi, Kamil F., Paster, Jeremy W., Sheth, Sohum, Freeman, Andrew M., Ramirez, Verity, Aggarwal, Monica

“…Cardiovascular disease is the leading cause of death in the United States. Poor dietary habits are not only a major modifiable risk factor for cardiovascular…”
Get full text

Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study by Quispe, Renato, Manalac, Raoul J, Faridi, Kamil F, Blaha, Michael J, Toth, Peter P, Kulkarni, Krishnaji R, Nasir, Khurram, Virani, Salim S, Banach, Maciej, Blumenthal, Roger S, Martin, Seth S, Jones, Steven R

“…Abstract Background High levels of the triglycerides to high-density lipoprotein cholesterol (TG/HDL-C) ratio are associated with obesity, metabolic syndrome,…”
Get full text

Watchman device migration and embolization: A report from the NCDR LAAO Registry by Friedman, Daniel J., Freeman, James V., Zimmerman, Sarah, Tan, Zhen, Pereira, Lucy, Faridi, Kamil F., Curtis, Jeptha P.

“…Introduction Incomplete anchoring of the Watchman left atrial appendage closure (LAAO) device can result in substantial device migration or device embolization…”
Get full text

Estimation of DAPT Study Treatment Effects in Contemporary Clinical Practice: Findings From the EXTEND-DAPT Study by Butala, Neel M., Faridi, Kamil F., Tamez, Hector, Strom, Jordan B., Song, Yang, Shen, Changyu, Secemsky, Eric A., Mauri, Laura, Kereiakes, Dean J., Curtis, Jeptha P., Gibson, C. Michael, Yeh, Robert W.

“…Differences in patient characteristics, changes in treatment algorithms, and advances in medical technology could each influence the applicability of older…”
Get full text

High- versus low-gradient aortic stenosis: Is our evaluation limited by aorto-mitral angle on cardiovascular CT? by See, Claudia, Kim, Yekaterina, Park, Jakob, Wang, Yanting, Reinhardt, Samuel W., Shkolnik, Evgeny, Faridi, Kamil F., Lombo, Bernardo, Bellumkonda, Lavanya, McNamara, Robert L., Sugeng, Lissa, Hur, David J.

“…Accurate assessment of aortic valve (AV) stenosis (AS) on transthoracic echocardiogram is crucial for appropriate clinical management. However, discordance…”
Get full text

Trends in Spending and Claims for P2Y12 Inhibitors by Medicare and Medicaid From 2015 to 2020 by Essa, Mohammed, Ross, Joseph S, Dhruva, Sanket S, Desai, Nihar R, Yeh, Robert W, Faridi, Kamil F

Get full text

Deficient serum 25-hydroxyvitamin D is associated with an atherogenic lipid profile: The Very Large Database of Lipids (VLDL-3) study by Lupton, Joshua R., MPH, MPhil, Faridi, Kamil F., MD, Martin, Seth S., MD, MHS, Sharma, Sristi, MD, MPH, Kulkarni, Krishnaji, PhD, Jones, Steven R., MD, Michos, Erin D., MD, MHS

“…Background Cross-sectional studies have found an association between deficiencies in serum vitamin D, as measured by 25-hydroxyvitamin D (25[OH]D), and an…”
Get full text

Association Between Claims-Defined Frailty and Outcomes Following 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study by Faridi, Kamil F, Strom, Jordan B, Kundi, Harun, Butala, Neel M, Curtis, Jeptha P, Gao, Qi, Song, Yang, Zheng, Luke, Tamez, Hector, Shen, Changyu, Secemsky, Eric A, Yeh, Robert W

“…Background Frailty is rarely assessed in clinical trials of patients who receive dual antiplatelet therapy (DAPT) after percutaneous coronary intervention…”
Get full text

Impact of Preprocedure Imaging for Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry by Clarke, John-Ross D, Higgins, Angela Y, Wang, Yongfei, Faridi, Kamil F, Curtis, Jeptha A, Freeman, James V, Friedman, Daniel J

“…The impact of preprocedure imaging on the safety and effectiveness of left atrial appendage occlusion (LAAO) remains unclear. This study sought to determine…”
Get full text

Moving toward combination lipid-lowering therapy for all patients with atherosclerotic cardiovascular disease by Faridi, Kamil F., Desai, Nihar R.

Get full text

Rationale and design of a pragmatic trial aimed at improving treatment of hyperlipidemia in outpatients with very high risk atherosclerotic cardiovascular disease: A pragmatic trial of messaging to providers about treatment of hyperlipidemia (PROMPT-LIPID) by Shah, Nimish N., Ghazi, Lama, Yamamoto, Yu, Martin, Melissa, Simonov, Michael, Riello, Ralph J., Faridi, Kamil F., Ahmad, Tariq, Wilson, F. Perry, Desai, Nihar R.

“…Despite guideline recommendations to optimize low-density lipoprotein cholesterol (LDL-C) reduction with intensification of lipid-lowering therapy (LLT) in…”
Get full text

New Heart Failure After Myocardial Infarction (From the National Cardiovascular Data Registries [NCDR] Linked With All-Payer Claims) by Faridi, Kamil F., Bhalla, Narinder, Atreja, Nipun, Venditto, John, Khan, Naeem D., Wilson, Thomas, Fonseca, Eileen, Shen, Changyu, Yeh, Robert W., Secemsky, Eric A.

“…•After MI, 18.8% of patients develop new HF within 5 years after discharge.•CKD and recurrent MI are the strongest risk factors for new HF after MI.•A simple…”
Get full text

Demographic and State-Level Trends in Mortality Due to Ischemic Heart Disease in the United States from 1999 to 2019 by Essa, Mohammed, Ghajar, Alireza, Delago, Augustin, Hammond-Haley, Matthew, Shalhoub, Joseph, Marshall, Dominic, Salciccioli, Justin D., Sugeng, Lissa, Philips, Binu, Faridi, Kamil F.

“…Although there have been advances in ischemic heart disease (IHD) care, variation in IHD-related mortality trends across the United States has not been well…”
Get full text

Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy by Gupta, Rajan T., M.D, Faridi, Kamil F., M.D, Singh, Abhay A., M.D, Passoni, Niccolò M., M.D, Garcia-Reyes, Kirema, M.D, Madden, John F., M.D., Ph.D, Polascik, Thomas J., M.D., F.A.C.S

“…Abstract Objectives The purpose of our study was to test our hypothesis that multiparametric magnetic resonance imaging (mpMRI) may have a higher prognostic…”
Get full text